Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-14

Clinical Trial Update: The Forteo Alendronate Comparator Trial [Phase 4]

View source ↗

Summary

This update reports that a Phase 4 trial comparing Forteo (teriparatide) to alendronate for osteoporosis has completed. The snippet does not include trial resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Forteo (teriparatide)
  • alendronate (alendronate)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED